Protalix Biotherapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $335k | 151k | 2.22 |
| 2025-03-31 | $741k | 290k | 2.56 |
| 2024-12-31 | $94k | 50k | 1.88 |
| 2024-09-30 | $51k | 50k | 1.02 |
| 2024-06-30 | $541k | 462k | 1.17 |
| 2024-03-31 | $117k | 92k | 1.26 |
| 2023-12-31 | $186k | 105k | 1.78 |
| 2023-09-30 | $179k | 108k | 1.66 |
| 2023-06-30 | $100k | 50k | 2.00 |